Zeng Zhimou, Song Ping, Gui Xingyu, Ake Bicheng, Liu Taoyu, Liu Hao, Wang Linnan, Wang Lei, Song Yueming, Qu Bo, Zhou Changchun
School of Clinical Medicine, Chengdu Medical College, Chengdu 610500, China.
Department of Orthopedic Surgery, The First Affiliated Hospital of Chengdu Medical College, Chengdu 610500, China.
Regen Biomater. 2025 May 5;12:rbaf029. doi: 10.1093/rb/rbaf029. eCollection 2025.
The repair of large bone defects continues to pose a significant challenge in clinical orthopedics. Successful repairs require not only adequate mechanical strength but also exceptional osteogenic activity for successful clinical translation. Composite materials based on polyamide 66 (PA66) and hydroxyapatite have been widely used in various clinical settings. However, existing PA66/hydroxyapatite composites often lack sufficient osteogenic stimulation despite their favorable mechanical properties, which limit their overall clinical efficacy. In this study, we fabricated a polyamide 66/nano-hydroxyapatite (PAHA) scaffold using an extruder and fused deposition modeling-based 3D printing technology. Subsequently, gelatin methacrylamide (GelMA) containing teriparatide (PTH) was incorporated into the PAHA scaffold to construct the Gel/PTH@PAHA scaffold. Material characterization results indicated that the compressive modulus of elasticity and compressive strength of the Gel/PTH@PAHA scaffold were 172.47 ± 5.48 MPa and 25.55 ± 2.19 MPa, respectively. evaluations demonstrated that the Gel/PTH@PAHA scaffold significantly enhanced osteoblast adhesion and proliferation while promoting osteogenic differentiation of BMSCs. studies further revealed that this scaffold notably promoted new bone regeneration in rabbit femoral defects. These findings suggest that the 3D-printed Gel/PTH@PAHA scaffold exhibits excellent mechanical properties alongside remarkable osteogenic activity, thereby meeting the dual requirements for load-bearing applications and bone regeneration. This innovative approach may be a promising candidate for customized orthopedic implants with substantial potential for clinical application.
在临床骨科中,大骨缺损的修复仍然是一项重大挑战。成功的修复不仅需要足够的机械强度,还需要卓越的成骨活性才能实现成功的临床转化。基于聚酰胺66(PA66)和羟基磷灰石的复合材料已广泛应用于各种临床场景。然而,现有的PA66/羟基磷灰石复合材料尽管具有良好的机械性能,但往往缺乏足够的成骨刺激,这限制了它们的整体临床疗效。在本研究中,我们使用挤出机和基于熔融沉积建模的3D打印技术制备了聚酰胺66/纳米羟基磷灰石(PAHA)支架。随后,将含有特立帕肽(PTH)的甲基丙烯酰化明胶(GelMA)掺入PAHA支架中,构建Gel/PTH@PAHA支架。材料表征结果表明,Gel/PTH@PAHA支架的压缩弹性模量和压缩强度分别为172.47±5.48MPa和25.55±2.19MPa。评估表明,Gel/PTH@PAHA支架显著增强了成骨细胞的粘附和增殖,同时促进了骨髓间充质干细胞的成骨分化。进一步的研究表明,该支架显著促进了兔股骨缺损处的新骨再生。这些发现表明,3D打印的Gel/PTH@PAHA支架具有优异的机械性能以及显著的成骨活性,从而满足了承重应用和骨再生的双重要求。这种创新方法可能是定制骨科植入物的一个有前途的候选方案,具有很大的临床应用潜力。